Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$88,834,192
+$70,466,865 QoQ
Shares Held
245,317
+337.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#160
of 3,131 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. AMGN ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in AMGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,834,192 | 245,317 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $18,367,327 | 56,116 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $17,646,530 | 62,532 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $59,836,099 | 214,305 | Shares | Defined | 2025-08-13 | |
| 2024-12-31 | $8,798,163 | 33,756 | Shares | Defined | 2025-02-12 | |
| 2024-06-30 | $11,645,948 | 37,273 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,049,140 | 3,690 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $101,639,867 | 457,796 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $165,228,389 | 683,468 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $248,992,175 | 948,036 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $351,731,065 | 1,560,475 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $332,275,296 | 1,365,702 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $323,547,905 | 1,337,970 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $113,628,972 | 505,085 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $73,161,807 | 344,048 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $176,411,868 | 723,741 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $528,816 | 2,300 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $1,721,306 | 7,298 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $15,904,371 | 78,451 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||